Want to track TERN and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Terns Pharmaceuticals, Inc. (TERN) Statistics
Valuation metrics
Market Cap 4.77B
Enterprise value 5.09B
Trailing P/E (ttm) -47.28
Forward P/E -34.01
PEG ratio -34.01
Price/Sales (ttm) -
Price/Book (mrq) 5.91
Enterprise Value/Revenue -
Enterprise Value/EBITDA -46.29
Overview
Shares outstanding 112.32M
Float 115.12M
Shares short 8.06M
% Held by insiders 0%
% Held by institutions 1.1%
Average volume (10 days) 2.44M
Average volume (90 days) 6.66M
Price summary
52-Week low 2.65
52-Week high 53.19
Beta -0.38
50-Day moving average 50.15
200-Day moving average 29.48
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Dec 2025
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -0.1%
Return on equity -0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -110.03M
Net income to common (ttm) -96.21M
Diluted EPS (ttm) -1.03
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 1.02B
Total cash per share (mrq) 8.83
Total debt (mrq) 919K
Total Debt/Equity (mrq) 0.09
Current ratio (mrq) 62.41%
Book value per share (mrq) 8.96
Cash Flow
Cash flow statement -82.18M
Levered free cash flow (LFCF) -55.48M
